Plasma Levels of Growth Differentiation Factor-15 and Adverse Kidney Outcomes
Clinical Journal of the American Society of Nephrology · 2026-11 · 21 (11) · 1899-1913
DOI: 10.2215/cjn.0000001177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 25.08.2026. Verfasst von Hee Byung Koh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Renal Insufficiency, Chronic, Glomerular Filtration Rate. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Key Points Elevated growth differentiation factor-15 was associated with higher CKD risk, whereas Mendelian randomization suggested a possible protective association with kidney function. Proteomics identified TNF receptor signaling, extracellular matrix organization, and leukocyte chemotaxis as candidate pathways. Growth differentiation factor-15 may serve as a prognostic biomarker, while its possible protective role and underlying mechanisms require further study.
Background
Growth differentiation factor-15 (GDF-15) has been implicated in adverse outcomes in cardiovascular disease and diabetes, highlighting its potential as a prognostic marker. However, its association with CKD development remains unclear. Therefore, we investigated the association between GDF-15 and incident CKD and explored potential causal mechanisms.
Methods
We analyzed 31,965 UK Biobank participants without preexisting CKD. The primary outcome was incident CKD, defined by diagnostic codes or an eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.
- Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
- Statistician Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Nephrology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
ORCID-Profile: Hee Byung Koh, Hyo Jeong Kim, Seok-Jae Heo, Cheol Ho Park, Young Su Joo, Tae Ik Chang, Jung Tak Park, Tae-Hyun Yoo, Seung Hyeok Han
Zitieren
APA
Koh, H. B., Kim, H. J., Heo, S. J., Park, C. H., Kim, H. W., Joo, Y. S., Chang, T. I., Park, J. T., Yoo, T. H., Kang, S. W., & Han, S. H. (2026). Plasma Levels of Growth Differentiation Factor-15 and Adverse Kidney Outcomes. Clinical Journal of the American Society of Nephrology, 21(11), 1899-1913. https://doi.org/10.2215/cjn.0000001177
Vancouver
Koh HB, Kim HJ, Heo SJ, Park CH, Kim HW, Joo YS, et al. Plasma Levels of Growth Differentiation Factor-15 and Adverse Kidney Outcomes. Clinical Journal of the American Society of Nephrology. 2026;21(11):1899-1913. doi:10.2215/cjn.0000001177
BibTeX
@article{Koh2026,
author = {Koh, Hee Byung and Kim, Hyo Jeong and Heo, Seok-Jae and Park, Cheol Ho and Kim, Hyung Woo and Joo, Young Su and Chang, Tae Ik and Park, Jung Tak and Yoo, Tae-Hyun and Kang, Shin-Wook and Han, Seung Hyeok},
title = {Plasma Levels of Growth Differentiation Factor-15 and Adverse Kidney Outcomes},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {11},
pages = {1899--1913},
doi = {10.2215/cjn.0000001177}
}
EUVIMED